|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0568 SEK | -0.35% |
|
+9.23% | -64.59% |
| 06-13 | Chordate Medical Holding AB Enters New Partnership Agreement with Neurolite AG | CI |
| 05-24 | Chordate Medical Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chordate Medical Holding AB (publ) reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 0.651052 million compared to SEK 0.020347 million a year ago. Revenue was SEK 0.67424 million compared to SEK 0.040655 million a year ago.
Net loss was SEK 9.84 million compared to SEK 8.08 million a year ago. Basic loss per share from continuing operations was SEK 0.04 compared to SEK 0.05 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -64.59% | 2.63M | |
| +7.77% | 218B | |
| +10.16% | 189B | |
| +26.21% | 151B | |
| +32.78% | 113B | |
| +1.98% | 64.02B | |
| +14.48% | 52.6B | |
| +2.92% | 49.85B | |
| -6.60% | 37.89B | |
| -1.07% | 34.92B |
CHORDATE MEDICAL HOLDING AB 
